NOT-EB-21-020: Notice of Change to NOT-EB-21-005 "NIBIB Guidance for Support of Clinical Trial Applications"

Notice of Change to NOT-EB-21-005 "NIBIB Guidance for Support of Clinical Trial Applications"

Notice Number:

NOT-EB-21-020

Key Dates

Release Date:

August 30, 2021

Related Announcements

PA-21-261 - PHS 2021-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)

PA-21-260 - PHS 2021-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

This notice informs applicants of the addition of PA-21-261 “PHS 2021-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)” and PA-21-26 0“PHS 2021-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)” to NOT-EB-21-005 "NIBIB Guidance for Support of Clinical Trial Applications.

Inquiries

Please direct all inquiries to:

Ilana Goldberg, Ph.D.
National Institute of Biomedial Imaging and Bioengineering (NIBIB)
Phone: 301-402-3465
Email: [email protected]